Using T cells to target malignant brain tumors

Doctors and scientists have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental model in mice.

from Latest Science News -- ScienceDaily https://ift.tt/3DnwZ98

Comments

Post a Comment

Popular posts from this blog

Single psilocybin trip delivers two years of depression relief for cancer patients

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy significantly reduced emotional suffering, and these effects often lasted over two years. As follow-up studies expand the research to multiple doses and larger samples, scientists are eyeing a possible new standard of care that merges psychedelics with psychological support. from Latest Science News -- ScienceDaily https://ift.tt/P1Aoby3
Read more